Show simple item record

TransHERA: The cell cycle regulator p27 predicts benefit from trastuzumab treatment in HER2-positive early breast cancer patients treated within the HERA trial

dc.contributor.authorFilipits, M
dc.contributor.authorGnant, M
dc.contributor.authorDafni, U
dc.contributor.authorPolydoropoulou, V
dc.contributor.authorHills, MJ
dc.contributor.authorLeyland-Jones, B
dc.contributor.authorPiccart-Gebhart, M
dc.contributor.authorDowsett, M
dc.coverage.spatialSan Antonio, TX
dc.date.accessioned2018-03-16T10:05:48Z
dc.date.issued2015-05-01
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000356730203150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationCANCER RESEARCH, 2015, 75 pp. ? - ? (2)
dc.identifier.issn0008-5472
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1596
dc.identifier.eissn1538-7445
dc.identifier.doi10.1158/1538-7445.SABCS14-P5-18-01
dc.format.extent? - ? (2)
dc.languageeng
dc.language.isoeng
dc.publisherAMER ASSOC CANCER RESEARCH
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.source37th Annual CTRC-AACR San Antonio Breast Cancer Symposium
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.titleTransHERA: The cell cycle regulator p27 predicts benefit from trastuzumab treatment in HER2-positive early breast cancer patients treated within the HERA trial
dc.typeConference Proceeding
rioxxterms.versionofrecord10.1158/1538-7445.SABCS14-P5-18-01
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2015-05-01
rioxxterms.typeConference Paper/Proceeding/Abstract
dc.relation.isPartOfCANCER RESEARCH
pubs.finish-date2014-12-13
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.)
pubs.publication-statusPublished
pubs.start-date2014-12-09
pubs.volume75
pubs.embargo.termsNot known
icr.researchteamEndocrinologyen_US
dc.contributor.icrauthorDowsett, Mitch


Files in this item

Thumbnail
Name:
CCR-17-3473R_Manuscript.pdf
Size:
2.260Mb
Format:
PDF
Description:
Accepted version
View/Open
Thumbnail
Name:
CCR-17-3473R_Figure 2.pdf
Size:
244.5Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following collection(s)

Show simple item record